Deficient nitric oxide responsible for reduced nerve blood flow in diabetic rats: Effects of L-NAME, L-arginine, sodium nitroprusside and evening primrose oil

被引:29
作者
Omawari, N
Dewhurst, M
Vo, P
Mahmood, S
Stevens, E
Tomlinson, DR
机构
[1] UNIV LONDON QUEEN MARY & WESTFIELD COLL,DEPT PHARMACOL,LONDON E1 4NS,ENGLAND
[2] UNIV LONDON QUEEN MARY & WESTFIELD COLL,WILLIAM HARVEY RES INST MED SCI,LONDON E1 4NS,ENGLAND
关键词
blood flow; diabetes mellitus; diabetic neuropathy; nitric oxide; rat nerve; streptozotocin;
D O I
10.1111/j.1476-5381.1996.tb15384.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 This study examined the potential role of impaired nitric oxide production and response in the development of endoneurial ischaemia in experimental diabetes. Rats were anaesthetized (Na pentobarbitone 45 mg kg(-1), diazepam 2 mg kg(-1)) for measurement of sciatic nerve laser Doppler flux and systemic arterial pressure. Drugs were administered into the sciatic endoneurium via a microinjector attached to a glass micropipette. 2 In two separate studies comparing diabetic rats (streptozotocin-induced; 8-10 wk duration) with controls, nerve Doppler flux in diabetic rats (Study 1, 116.6+/-40.4 and Study 2, 90.1+/-34.7 (s.d.) in arbitrary units) was about half that measured in controls (219.6+/-52.4 and 212.8+/-95.5 respectively; P<0.005 for both). There were no significant differences between the two in systemic arterial pressure. 3 Inhibition of nitric oxide production by microinjection of 1 nmol L-NAME into the endoneurium halved flux in controls (to 126.3+/-41.3 in Study 1 and 102.1+/-38.9 in Study 2; both P<0.001), with no significant effect in diabetic rats, indicating markedly diminished tonic nitric oxide production in the latter. D-NAME was without effect on nerve Doppler flux. 4 L-Arginine (100 nmol), injected after L-NAME, markedly increased flux in controls (by 65.8% (P<0.03) and 97.8% (P<0.01) in the two studies) and by proportionally similar amounts in diabetic rats [75.8% (P<0.001) and 60.2% (P<0.02)]. The nitro-donor, sodium nitroprusside (SNP; 10 nmol) had similar effects to L-arginine in both groups (increases of 66.0% in controls and 77.5% in diabetics; both P<0.002). 5 A second diabetic group, treated with evening primrose oil performed exactly like control rats in respect of responses to L-NAME, L-arginine and SNP. 6 These findings implicate deficient nitric oxide in nerve ischaemia of diabetes and suggest correction thereof as a mechanism of action of evening primrose oil.
引用
收藏
页码:186 / 190
页数:5
相关论文
共 22 条
  • [11] MODULATION OF THE INDUCTION OF NITRIC-OXIDE SYNTHASE BY EICOSANOIDS IN THE MURINE MACROPHAGE CELL-LINE J774
    MAROTTA, P
    SAUTEBIN, L
    DIROSA, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (03) : 640 - 641
  • [12] REGIONAL BLOOD-FLOW IN RESTING AND STIMULATED SCIATIC-NERVE OF DIABETIC RATS
    MONAFO, WW
    ELIASSON, SG
    SHIMAZAKI, S
    SUGIMOTO, H
    [J]. EXPERIMENTAL NEUROLOGY, 1988, 99 (03) : 607 - 614
  • [13] NERVE ISCHEMIA IN DIABETIC RATS - TIME-COURSE OF DEVELOPMENT, EFFECT OF INSULIN-TREATMENT PLUS COMPARISON OF STREPTOZOTOCIN AND BB MODELS
    STEVENS, EJ
    CARRINGTON, AL
    TOMLINSON, DR
    [J]. DIABETOLOGIA, 1994, 37 (01) : 43 - 48
  • [14] ESSENTIAL FATTY-ACID TREATMENT PREVENTS NERVE ISCHEMIA AND ASSOCIATED CONDUCTION ANOMALIES IN RATS WITH EXPERIMENTAL DIABETES-MELLITUS
    STEVENS, EJ
    LOCKETT, MJ
    CARRINGTON, AL
    TOMLINSON, DR
    [J]. DIABETOLOGIA, 1993, 36 (05) : 397 - 401
  • [15] PROSTACYCLIN RELEASE IN EXPERIMENTAL DIABETES - EFFECTS OF EVENING PRIMROSE OIL
    STEVENS, EJ
    CARRINGTON, AL
    TOMLINSON, DR
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1993, 49 (03): : 699 - 706
  • [16] EFFECTS OF ENDOTHELIN RECEPTOR ANTAGONISM WITH BOSENTAN ON PERIPHERAL-NERVE FUNCTION IN EXPERIMENTAL DIABETES
    STEVENS, EJ
    TOMLINSON, DR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (02) : 373 - 379
  • [17] STEVENS EJ, 1993, BRIT J PHARMACOL, V110, pP28
  • [18] COINDUCTION OF NITRIC-OXIDE SYNTHASE AND CYCLOOXYGENASE - INTERACTIONS BETWEEN NITRIC-OXIDE AND PROSTANOIDS
    SWIERKOSZ, TA
    MITCHELL, JA
    WARNER, TD
    BOTTING, RM
    VANE, JR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (07) : 1335 - 1342
  • [19] SZAMEL M, 1981, J BIOL CHEM, V256, P1618
  • [20] VASCULAR FACTORS IN DIABETIC NEUROPATHY
    TESFAYE, S
    MALIK, R
    WARD, JD
    [J]. DIABETOLOGIA, 1994, 37 (09) : 847 - 854